“How many women will have to die after taking this drug?” asked Randall O’Bannon of National Right to Life.
“One death is
too many. But after at least seven American deaths and at least 12
reported deaths worldwide, it is clear that this drug should not be
given to women,” said the organization’s director of education and
To date, the FDA
has directly linked to the drug to the deaths of seven women. As well,
the FDA has received more than 800 reports of complications caused by
the drug. The FDA admits that only 10 percent of complications from
drugs get reported.
abortion involves bleeding, pain, and cramping, often accompanied by
nausea, vomiting, and diarrhea. The expectation of these side effects
often causes women and doctors to overlook important signs of infection
or serious conditions, like ectopic pregnancy.
to Life claims that many deaths and injuries related to the drug may
never be reported. Reporting is voluntary, and women going to the
emergency room may never tell the doctor they have taken the drug, the
organization explained in a press release.
communiqué, Concerned Women for America pointed out that the FDA has
pulled other drugs that have caused fewer deaths and less severe
complications than RU-486.
NeutroSpec, an imaging agent used to diagnose internal infections, was
pulled after being linked to two deaths, 20 severe reactions, and 46
other "less" severe reactions.
Tysabri, a drug
to treat multiple sclerosis, was pulled after reports that three
patients taking it had developed PML, a rare brain disease.
to treat irritable bowel syndrome, was taken off the market after 70
patients had developed severe problems, and five patients died.
statistics, the CWA is wondering why the FDA is slacking in pulling
Mifeprex off the shelf. Mifeprex is distributed by Danco.
pro-life groups are wondering why the Food and Drug Administration
(FDA) still has not pulled Mifeprex, an abortion drug more commonly
known as RU-486, after reporting March 17 that two more women died
after taking it.